Characteristic | OR (95% CI) | L-R Chi-Square | P-Value |
---|---|---|---|
Survey Year | Â | 104.4 | < 0.001 |
   1996 | 1.00 (reference) |  |  |
   1997 | 1.78 (1.41–2.25) |  |  |
   1998 | 1.47 (1.17–1.86) |  |  |
   1999 | 0.62 (0.47–0.81) |  |  |
   2000 | 0.94 (0.72–1.22) |  |  |
   2001 | 0.91 (0.71–1.17) |  |  |
   2002 | 0.91 (0.71–1.17) |  |  |
   2003 | 1.07 (0.85–1.36) |  |  |
   2004 | 0.74 (0.58–0.95) |  |  |
   2005 | 0.65 (0.49–0.86) |  |  |
   2006 | 0.72 (0.56–0.93) |  |  |
Race | Â | 18.4 | < 0.001 |
   White | 1.00 (reference) |  |  |
   Black | 1.20 (1.10–1.30) |  |  |
Age | Â | 26.4 | < 0.001 |
   18–34 | 1.00 (reference) |  |  |
   35–49 | 0.98 (0.83–1.17) |  |  |
   50–64 | 1.34 (1.09–1.64) |  |  |
   ≥ 65 | 1.10 (0.70–1.67) |  |  |
Gender | Â | 0.3 | 0.6 |
   Female | 1.00 (reference) |  |  |
   Male | 1.02 (0.94–1.11) |  |  |
Insurance Status | Â | 8.4 | 0.04 |
   Uninsured | 1.00 (reference) |  |  |
   Government | 1.22 (1.04–1.43) |  |  |
   Private | 0.96 (0.80–1.16) |  |  |
   Other insurance | 0.89 (0.62–1.27) |  |  |
Presence of Comorbidities* | Â | Â | Â |
   Preventable OI | 1.97 (1.77–2.20) | 142.9 | < 0.001 |
   Non-preventable OI | 2.03 (1.86–2.22) | 238.0 | < 0.001 |
   HBV | 1.05 (0.84–1.31) | 0.2 | 0.7 |
   HCV | 1.04 (0.90–1.19) | 0.3 | 0.6 |
   Cocaine use | 0.98 (0.93–1.12) | 0.1 | 0.8 |